Jan. 14, 2020

I was speaking with our intern Usif Darwish, PharmD Candidate, Florida A&M University, about the causes of type 1 diabetes, and he focused on autoimmune problems destroying the beta cells.

He wondered out loud if using an autoimmune blocking drug would prevent diabetes in relatives of patients already diagnosed.

As you probably guessed, his thought became his assignment, and this week he brings us a feature on the value of using a monoclonal antibody drug.

 

*****************************

We can make a difference!

*****************************

Dave Joffe

Editor-in-chief